# OnCo record nct05367440 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05367440/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05367440", "NCT05367440" ;
  schema:name "Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer"@en ;
  schema:alternateName "PETRANHA"@en ;
  schema:description "A phase 1/2 trial of Saruparib, Enzalutamide, Abiraterone acetate in prostate cancer, run by AstraZeneca, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05367440/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05367440> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2022-06-02" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:drugs <https://onco.cc/drugs/saruparib/>, <https://onco.cc/drugs/enzalutamide/>, <https://onco.cc/drugs/abiraterone/>, <https://onco.cc/drugs/darolutamide/>, <https://onco.cc/drugs/apalutamide/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> .